Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 3001 AL 3015

Cognitive outcomes in trials of two BACE inhibitors in Alzheimer's disease

Wessels AM, Lines C, Stern RA, Kost J, Voss T, Mozley LH, Furtek C, Mukai Y, Aisen PS, Cummings JL, Tariot PN, Vellas B, Dupre N, Randolph C, Michelson D, Andersen SW, Shering C, Sims JR, Egan MF.

Alzheimers Dement. 2020 Nov;16(11):1483-1492. doi: 10.1002/alz.12164. Epub 2020 Oct 13.

The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease

Feng YS, Tan ZX, Wu LY, Dong F, Zhang F.

Ageing Res Rev. 2020 Dec;64:101192. doi: 10.1016/j.arr.2020.101192. Epub 2020 Oct 13.

Scope of β-Secretase (BACE1)-Targeted Therapy in Alzheimer's Disease: Emphasizing the Flavonoid Based Natural Scaffold for BACE1 Inhibition

Das S, Sengupta S, Chakraborty S.

ACS Chem Neurosci. 2020 Nov 4;11(21):3510-3522. doi: 10.1021/acschemneuro.0c00579. Epub 2020 Oct 19.

The Glucose Metabolic Pathway as A Potential Target for Therapeutics: Crucial Role of Glycosylation in Alzheimer's Disease

Bukke VN, Villani R, Archana M, Wawrzyniak A, Balawender K, Orkisz S, Ferraro L, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 19;21(20):7739. doi: 10.3390/ijms21207739.

Caenorhabditis elegans as a possible model to screen anti-Alzheimer's therapeutics

Paul D, Chipurupalli S, Justin A, Raja K, Mohankumar SK.

J Pharmacol Toxicol Methods. 2020 Nov-Dec;106:106932. doi: 10.1016/j.vascn.2020.106932. Epub 2020 Oct 20.

Physical exercise protocols in animal models of Alzheimer's disease: a systematic review

De Sousa RAL, Rodrigues CM, Mendes BF, Improta-Caria AC, Peixoto MFD, Cassilhas RC.

Metab Brain Dis. 2021 Jan;36(1):85-95. doi: 10.1007/s11011-020-00633-z. Epub 2020 Oct 23.

Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease

Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C.

Neuron. 2020 Dec 9;108(5):801-821. doi: 10.1016/j.neuron.2020.09.029. Epub 2020 Oct 22.

Studying the Relationship of Intermittent Fasting and β-Amyloid in Animal Model of Alzheimer's Disease: A Scoping Review

Nasaruddin ML, Syed Abd Halim SA, Kamaruzzaman MA.

Nutrients. 2020 Oct 21;12(10):3215. doi: 10.3390/nu12103215.

Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease

Manek E, Darvas F, Petroianu GA.

Molecules. 2020 Oct 21;25(20):4866. doi: 10.3390/molecules25204866.

Structure and therapeutic uses of butyrylcholinesterase: Application in detoxification, Alzheimer's disease, and fat metabolism

Xing S, Li Q, Xiong B, Chen Y, Feng F, Liu W, Sun H.

Med Res Rev. 2021 Mar;41(2):858-901. doi: 10.1002/med.21745. Epub 2020 Oct 25.

Critical thinking on amyloid-beta-targeted therapy: challenges and perspectives

Sun BL, Chen Y, Fan DY, Zhu C, Zeng F, Wang YJ.

Sci China Life Sci. 2021 Jun;64(6):926-937. doi: 10.1007/s11427-020-1810-y. Epub 2020 Oct 23.

Attenuation of Nrf2/Keap1/ARE in Alzheimer's Disease by Plant Secondary Metabolites: A Mechanistic Review

Fakhri S, Pesce M, Patruno A, Moradi SZ, Iranpanah A, Farzaei MH, Sobarzo-Sánchez E.

Molecules. 2020 Oct 24;25(21):4926. doi: 10.3390/molecules25214926.

Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression

Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M.

Sci Rep. 2020 Oct 29;10(1):18627. doi: 10.1038/s41598-020-73729-2.

Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance

Wang L, Bharti, Kumar R, Pavlov PF, Winblad B.

Eur J Med Chem. 2021 Jan 1;209:112915. doi: 10.1016/j.ejmech.2020.112915. Epub 2020 Oct 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias